62
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Carnitine and Antioxidants Levels in Patients with Rheumatoid Arthritis

Pages 441-445 | Published online: 12 Jul 2009

References

  • Horton AA, Fairhurst S. Lipid peroxidation and mechanisms of toxicity. Crit Rev Toxicol 1987;18:27–79.
  • Jurgens G, Hoff HF, Chisolm GM, Esterbauer H. Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications. Chem Phys Lipids 1987;45:315–36.
  • Hidalgo J, Gasull T, Garcia A, Blanguez A, Armario A. Role of glucocorticoids and catecholamines on hepatic thiobarbitu-ric acid reactants in basal and stress conditions in the rat. Horm Metab Res 1991;23:104–9.
  • Halliwell B. Drug antioxidant effects. A basis for drug selec-tion? Drugs 1991;42:569–605.
  • Bremer J. Carnitine metabolism and functions. Physiol Rev 1983;63:1421–80.
  • Pola P, Savi L, Grill M, Velardi F, Lago A. Carnitine in the therarpy of dyslipemic patients. Curr Ther Res 1980;27:208–16.
  • Lacour B, Chanard J, Haguet M, DiGiulio S, Chanard J, Ciancioni C, et al. Carnitine improves lipid anomalies in hae-modialysis patients. Lancet 1980;12:763–4.
  • Seccombe DW, James L, Hahn P. Type V hyperlipoproteinemia with palmar erythema and eruptive xanthomas, effects of treat-ment with L-carnitine. 111 International Colloquium on Lipid Metabolism and its Pathology, Lisbon, Portugal. Sept. 1982:22–5.
  • Avogaro P, Bon GB, Cazzolato G, Rorai E. Acute effect of L-carnitine on FFA and 13-Hydroxy-Butyrate in Man. Pharmacol Res Commun 1981;13:443–50.
  • Orzali A, Donzelli F, Enzi G, Rubaltelli FF. Effect of carnitine on lipid metabolism in the Newborn L-carnitine supplanenta-tion during total parenteral Nutrition in the first 48 hours of life. Biol Neonate 1983;43:186–90.
  • Vacha GM, Giorcelli G, Silliprandi N, Corsi M. Favourable effects of L-carnitine treatmenet on hyper triglyceridemia in hemodialysis patients: Decisive role of low levels of high-den-sity lipoprotein cholesterol. Am J Clin Nutr 1983;38:532–40.
  • Lerner A, Gruener N, Lancu TC. Serum carnitine concentra-tions in coeliac disease. Gut 1993;34:933–5.
  • Bieber LL, Emaus R, Valkner K, Farrell S. Possible functions of short chain and medium-chain carnitine acyltransferase. Fed Proc 1982;41:2858–63.
  • Chalmers RA, Stacey TE, Tracey BM, Sousa C, Roe CR, Millington DS, et al. L-carnitine insufficiency in disorders of organic acid metabolism response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3-methylglutaric aciduria. J Inherit Metab Dis 1984;7:109–10.
  • Pepper JR, Mumby S, Gutteridge JMC. Sequential oxidative damage and changes in iron-oxidising plasma antioxidant dur-ing cardiopulmonary bypass surgery. Free Radic Res 1994;21:377–85.
  • Gutteridge JMC, Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicalsby normal human plas-ma:the important primary role for iron-oxiding proteins. Bio-chim Biophys Acta 1993;1156:144–50.
  • Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;28:1–8.
  • Lowry OH, Rosenburg MY, Farr AL, Randall RT. Protein measurement with the folin phenol reagent. J Biol Chim 1951;193:265–75.
  • Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37–43.
  • Paynter DI. Changes in activity of the manganese superoxide dismutase enzyme in tissues of the rat with changes in dietary manganese. J Nutr 1986;110:437–47.
  • Misra HP, Fridovich I. Superoxide dismutase: Photochemical augmentation assay. Arch Biochem Biophys 1977;181:308–12.
  • Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121–6.
  • Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207–12.
  • Harparkash K, Barry H. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9–12.
  • Bhuiyan AKMJ, Jackson S, Turnbull DM, Aynsley-Green A, Leonard JV, Bartlett K. The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxi-dation. Clin Chem Acta 1992;207:185–204.
  • Stanley CA, Hale DE, Coates PM, Hall CL, Corkey BE, Yang W, et al. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res 1983;17:877–84.
  • Halliwel B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease:an overview. In: Packer L, Glazer AN, eds. Methods in enzymology:oxygen radicals in biological systems. B San Diego: Academic Press, 1990:1–83.
  • Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radi-cals, cell damage, and antioxidant therapy. Lancet 1984;8391:1396–2007.
  • Lunec J, Halloran SP, Whithe AG, Dormandy TL. Free radical oxidation products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 1981;8:233–45.
  • Rister M, Bauermeister K, Gravert U, Gladtke E. Superoxide dismutase deficiency in rheumatoid arthritis. Lancet 1978;8073:1094.
  • Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527–605.
  • Toth MK, Berger EM, Beehler CJ, Repine JE. Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from H202 better than do erythro-cytes from non-smokers. Am Rev Respir Dis 1986;134:281–4.
  • Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Glutathione cycle activity and pyridine nucleo-tide levels in oxidant-induced injury of cells. J Clin Invest 1985;76:1131–9.
  • Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL. The inhi-bition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol. Clin Sci (Colch) 1974;47:223–33.
  • Biemond P, Swaak AJG, Koster JF. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum 1984;27:760–5.
  • Denko CW. Protective role of ceruloplasmin in inflammation. Agents Actions 1979:333–6.
  • Scudder PR, Timmi D, McMurray W, While AG, Zoob BC, Dormandy TL. Serum copper and related variables in rheuma-toid arthritis. Ann Rheum Dis 1978;37:67–70.
  • Banford JC, Brown DH, Hazelton RA, McNeil CJ, Sturrock RD, Smit WE. Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis. Ann Rheum Dis 1982; 41:458–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.